AzTrials
AzTrials

Critically Ill Intensive Care Unit PatientsNCT01982877

The Four Supports Study: Family Support Intervention in Intensive Care Units

A study testing Four Supports Intervention in people with Critically Ill Intensive Care Unit Patients and Physician-Family Communication in Intensive Care Units, run by University of Pittsburgh at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to test the effectiveness of a multi-faceted communication intervention for family members of critically ill patients to reduce the family members' long-term symptoms of depression and anxiety. Read more about this study

Who is it for?
Ages 21 years and older
What is being tested?
Four Supports Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
546 participants
Where
1 siteUnited States
Study dates
Jan 2014to 19 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Patient Inclusion criteria:

  1. age ≥21,
  2. lack of decision making capacity as determined by clinical examination by the attending physician,
  3. APACHE II score ≥ 22, AND/OR
  4. > 40% risk of death in hospital or >40% chance of severe long term functional impairment as judged by the patient's attending physician.

Patient Exclusion Criteria:

  1. lack of a surrogate decision maker and
  2. impending organ transplantation.
  3. decisions regarding care and treatment already made
  4. not currently participating in competing research study
  5. Discharged prior to enrollment
  6. Incarcerated.

Surrogate Inclusion criteria:

  1. age ≥ 18 years,
  2. self-identify as being involved in surrogate decision-making for the patient, up to a total of four family/surrogates.
  3. able to give full informed consent, and
  4. able to complete written questionnaires.

Surrogate Exclusion Criteria:

  1. age <18 years old,
  2. unable to read and understand English, and
  3. unable to complete questionnaires due to physical or cognitive limitations.

Physician Inclusion criteria:

  1. Eligible physicians will be the patient's primary attending or his/her designee. If an enrolled patient is cared for by more than one attending physician during their ICU stay, each will be consented.

Physician Exclusion Criteria:

  1. Study investigators will be excluded as participants.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15216

Other trials in United States

About this study

Official title: A Trial to Improve Surrogate Decision-Making for Critically Ill Older Adults

The purpose of this study is to test the effectiveness of a multi-faceted communication intervention for family members of critically ill patients to reduce the family members' long-term symptoms of depression and anxiety.

Read the detailed description

One in four elderly Americans die in or shortly after discharge from an intensive care unit. An expanding body of literature documents that physician-family communication and end-of-life care is poor in intensive care units. These deficiencies are associated with high rates of adverse psychological outcomes among surrogates, physician-family conflict, and life support decisions that may be inconsistent with patients' goals and preferences. There is a lack of information on practical, generalizable interventions that effectively improve this important aspect of care for elderly patients and their families.

The primary aim of this study is to evaluate the effectiveness of a multifaceted communication intervention as compared to an educational control to improve psychological outcomes among family members of critically ill patients, using a randomized, controlled trial design.

This randomized controlled trial involves adding a Family Support Specialist (FSS) to the clinical team to provide four types of support to the families of patients with advanced critical illness: emotional support, communication support (between the clinical team and the family), decisional support (education about the role of a surrogate decision maker) and anticipatory grief support.

The overall aim of the study is to improve the long-term psychological outcomes for family members of critically ill patients, to improve the quality of communication and decision-making between physicians and families, and to improve the patient-centeredness of care.

What happens in the study?

Patient is randomized to one of two groups:

  1. INTERVENTION GROUP: Family Support Specialist is added to the clinical team to provide emotional support to the family and facilitate frequent communication with the clinical team.
  2. CONTROL GROUP: Receives usual care with the addition of two educational sessions provided by the FSS to teach family members about the ICU environment.

What do participants need to do?

Family Members: Interact with the Family Support Specialist daily. Family Support Specialist addresses family needs and ensures that their questions are addressed.

Physicians: Collaborate with the Family Support Specialist to determine how best to support the family as well as attending clinician-family meetings.

Sample size: With a sample size of 300 patients (450 surrogates), the study is well powered to detect small and clinically important differences in the primary outcome measure Hospital Anxiety and Depression Score (HADS).The trial's original sample size of 400 patients (600 surrogates) was chosen to maximize the power to detect differences in a secondary outcome measure (costs) that required a substantially larger sample size than the primary outcome (HADS). Since the original power calculations were conducted, new data were published which indicated that cost analysis in this context will require an even larger sample size based one effect modification from whether the patient lived or died. Therefore, the Data and Safety Monitoring Board recommended revising the sample size to power the trial on the primary outcome (HADS), which required 300 patients (450 surrogates).

Being tested
Four Supports Intervention, Educational Control Intervention
Keywords
decision making, values elicitation, patient centered care, Four Supports, Family Support

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Four Supports InterventionBehavioural

    The Four Supports Intervention is a multi-faceted intervention involving the addition of a trained nurse/social worker interventionist to the patient's care team who delivers four kinds of support: emotional support, communication support, decision support, and anticipatory grief support.

  • Educational Control InterventionBehavioural

    In addition to usual care, enrolled surrogates will receive two 15-minute education sessions about critical illness and mechanical ventilation on days 2 and 5, delivered by a research staff coordinator with education in critical care nursing.

Study groups in NCT01982877
Study groupRoleWhat they receive
Family Support InterventionExperimentalMultifaceted family support intervention as well as ICU educational component.
Receives: Behavioral: Four Supports Intervention; Behavioral: Educational Control Intervention
Educational ControlExperimentalICU educational component
Receives: Behavioral: Educational Control Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospital Anxiety and Depression Scale

    Burden of anxiety and depression will be measured in family members 6 months after enrollment using the validated 14-item Hospital Anxiety and Depression scale (HADS).

    Measured: participants will be followed six months following the patient's death or discharge from hospital, an expected average of 195 days

Secondary outcomes (5)
  1. Patient and family-centeredness of care

    Patient and family-centeredness of care measured using the 12-item Patient-Perceived Patient-Centeredness of Care Scale (PPPC) adapted to use by surrogates.

    Measured: At 6 months

  2. Total Hospital Costs

    he costs are measured using aggregate data form the date of hospital admission through hospital discharge

    Measured: Duration of hospital stay, an expected average of 4 weeks

  3. Intensive Care Unit Length of Stay

    The Intensive Care Unit length of stay , assessed by abstraction from hospital administrative records

    Measured: Participants will be followed for duration of ICU stay, an expected average of 21 days

  4. Hospital Length of stay

    Hospital length of stay length of stay , assessed by abstraction from hospital administrative records

    Measured: Participants will be followed for duration of hospital stay, an expected average of 4 weeks

  5. Impact of Events scale at 6 months

    Symptoms of post traumatic stress in family members assessed using the validated 22 item Impact of Events Scale.

    Measured: at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2013 (estimated)
  2. Study startJan 2014
  3. Primary completion19 Apr 2019
  4. Study completion19 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
546 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01982877
Sponsor's protocol ID
1R01AG045176-01
Status last verified
Jan 2020
First submitted
30 Oct 2013
Last updated
14 Jan 2020
Results posted
No
Data monitoring committee
Yes

Publications

  • Butler RA, Seaman JB, Felman K, Stonehouse W, San Pedro R, Morse JQ, Chang CH, Lincoln T, Reynolds CF 3rd, Landefeld S, Happ MB, Song MK, Angus DC, Arnold RM, White DB. Randomized Clinical Trial of the Four Supports Intervention for Surrogate Decision-Makers in Intensive Care Units. Am J Respir Crit Care Med. 2025 Mar;211(3):370-380. doi: 10.1164/rccm.202405-0931OC.

    PubMed 39586017
  • Seaman JB, Arnold RM, Buddadhumaruk P, Shields AM, Gustafson RM, Felman K, Newdick W, SanPedro R, Mackenzie S, Morse JQ, Chang CH, Happ MB, Song MK, Kahn JM, Reynolds CF 3rd, Angus DC, Landefeld S, White DB. Protocol and Fidelity Monitoring Plan for Four Supports. A Multicenter Trial of an Intervention to Support Surrogate Decision Makers in Intensive Care Units. Ann Am Thorac Soc. 2018 Sep;15(9):1083-1091. doi: 10.1513/AnnalsATS.201803-157SD.

    PubMed 30088971

Questions about this trial

What is this clinical trial studying?

A study testing Four Supports Intervention in people with Critically Ill Intensive Care Unit Patients and Physician-Family Communication in Intensive Care Units, run by University of Pittsburgh at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospital Anxiety and Depression Scale (time frame: participants will be followed six months following the patient's death or discharge from hospital, an expected average of 195 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01982877, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in